Roche receives CE mark for new blood test to detect Alzheimer's pathology
Published on 05/12/2026 at 03:23 pm AEST
Reuters
Share
Share
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 326.10 CHF | -1.18% |
|
+0.68% | -0.64% |
| 08:31am | FDA approves first generic version of Roche's flu drug | RE |
| 15/06 | Global drugmakers invest billions to boost US presence | RE |
Employees
103,249
Sector
Pharmaceuticals
Calendar
23/07 -
Earnings release - Q2 2026
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
AA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
327.80CHF
Average target price
358.83CHF
Spread / Average Target
+9.47%
Quarterly revenue - Rate of surprise
- Stock Market
- Stock Market News
- Roche receives CE mark for new blood test to detect Alzheimer's pathology
Select your edition
All financial news and data tailored to specific country editions
